Ferrari AF Corse’s No. 51 499P and BMW Team WRT’s No. 15 M Hybrid V8 ended up setting identical benchmark lap times in Free Practice 2 for the 6 Hours of Imola, with Antonio Giovinazzi and Dries ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Wall Street expects Elevance Health to post $11.09 EPS and $45.93 billion in revenue, reflecting solid year-over-year growth. This includes an 8.7% bump in total revenue and a 4.2% jump in earnings ...

Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to Neutral. Analyst Price Forecast Suggests 14.83% Upside As of April 1 ...

In the movies, sequels are rarely better than the original – but with the BMW M4 the opposite is true. It took a number of revisions before the previous-generation M4 really delivered the ...

The BMW 3 Series is 50 years old this year but you wouldn’t have guessed looking at how fit and athletic it is. And to emphasise that point, the BMW M340i xDrive Edition 50 Jahre is wearing a ...

Found the BMW Z3 of your dreams? Now you want to know all about it! With the help of Parkers, you can find out all of the key specs about the BMW Z3 from fuel efficiency in MPG and top speed in MPH, ...

BMW Motorrad also offers a range of seat options designed to suit a variety of rider heights, with the standard seat height being 785 mm. The R 1300 R carries 17-litres of fuel in the tank while ...

Below is Validea's guru fundamental report for ELEVANCE HEALTH INC (ELV). Of the 22 guru strategies we follow, ELV rates highest using our Low PE Investor model based on the published strategy of ...

The BMW F900R naked motorbike was launched alongside the half-faired F900XR adventure sports version in 2020 and, although good, in many ways the naked bike was the slightly poorer relation ...

Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Elevance Health (NYSE:ELV) with a Buy recommendation. Analyst Price Forecast Suggests 16.21% Upside As of April 1 ...